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Abstract 
 
Background. Non-communicable diseases (NCDs) cause 63% of deaths worldwide. The leading 
NCD risk factor is raised blood pressure, contributing to 13% of deaths. A large proportion of NCDs 
are preventable by modifying risk factor levels. Effective prevention programmes and health policy 
decisions need to be evidence based. Currently, self-reported information in general populations or 
data from patients receiving healthcare provides the best available information on the prevalence of 
obesity, hypertension, diabetes etc. in most countries.  
Methods. In the European Health Examination Survey Pilot Project, 12 countries conducted a 
pilot survey among the working age population. Information was collected using standardized 
questionnaires, physical measurement and blood sampling protocols. This allowed comparison of self-
reported and measured data on prevalence of overweight, obesity, hypertension, high blood cholesterol 
and diabetes. 
Results. Self-reported data under-estimated population means and prevalence for health indicators 
assessed. The self-reported data provided prevalence of obesity four percentage points lower for both 
men and women. For hypertension, the self-reported prevalence was ten percentage points lower, only 
in men. For elevated total cholesterol, the difference was 50 percentage point among men and 44 
percentage points among women. For diabetes, again only in men, the self-reported prevalence was 
one percentage point lower than measured. With self-reported data only, almost 70% of population at 
risk of elevated total cholesterol is missed compared with data from objective measurements.  
Conclusions. Health indicators based on measurements in the general population include 
undiagnosed cases, therefore providing more accurate surveillance data than reliance on self-reported 
or healthcare-based information only. 
Key words: health examination survey,  hypertension, obesity, diabetes, high cholesterol 
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Introduction  
 
Representative and accurate health information is needed for planning and evaluation of health 
policies and prevention activities. Information on the health, health behaviours and lifestyle of the 
general population can be obtained from administrative registers, or through health interview or health 
examination surveys. The availability and coverage of administrative registers on health issues vary 
between countries. The availability of health interview and health examination surveys, their coverage, 
the questions and measurements included, and the population groups covered also vary considerably 
between countries 
1
. 
Administrative registers such as medical records include people who have been diagnosed and 
treated by a physician. These registers represent the part of the population which has been seeking 
medical attention for their health conditions. In health interview and health examination surveys, a 
random sample of the population is taken. When a sample is selected from a sampling frame which 
covers the entire population, the selected sample should represent the entire population. In health 
interview surveys, the information obtained is based on self-reporting of the survey participants while 
in health examination surveys, objective measurements are also conducted. 
Several studies have compared the prevalence of health outcomes from these three different data 
sources: administrative registers, self-reported information from health interview surveys, and clinical 
measurements from health examination surveys and cohort studies. When self-reported information 
was compared with medical records or clinical measurements from health examination surveys, self-
reported information under-estimated the prevalence of hypertension 
2-12
 and high cholesterol 
6,10,12
. 
Some studies provided relatively close estimates for the prevalence of diabetes 
2,5,11,12
, while other 
studies slightly under-estimated the prevalence of diabetes 
3,4,6,8,10
. For height and weight, required for 
estimating the prevalence of overweight and obesity, data are not systematically available from 
administrative registers. Self-reported information under-estimates the prevalence of overweight and 
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obesity in comparison with clinical examinations 
13-15
. Prevalence of hypertension and high cholesterol 
have been under-estimated by medical records when compared with clinical examinations. However, 
for diabetes, the prevalence estimates have been relatively close between these two data sources. 
2
 
We compare self-reported information and objective measurements from the same individuals to 
examine whether population-level means and prevalences differ between these two data sources. We 
also assess the extent of any discrepancies, and how it varies between countries across Europe.  
Material and methods 
 
The European Health Examination Survey (EHES) Pilot Project (http://www.ehes.info) was 
conducted in 2009-2011. In 12 countries (Czech Republic, Finland, Germany, Greece, Italy, Malta, 
Netherlands, Norway, Poland, Portugal, Slovakia and UK/England) a pilot health examination survey 
of adults aged 25-64 years in the general population was conducted 
16
. Random samples of the 
population were selected from the best available sampling frames in each country. Examinations and 
interviews were conducted by specially trained fieldwork personnel. 
17
 The total number of 
participants in these surveys was 4127 (44% men). Samples were not representative for the countries, 
limiting country level comparisons. The surveys included questionnaire(s), physical measurements and 
collection of blood samples. 
16
 Each survey received ethical approval from the appropriate ethical 
committee(s) and the survey participants gave informed consent before the measurements were taken.  
Measurement data 
The measurements were conducted using standardized protocols. 
18
 Height (cm) and weight (kg) 
were measured without shoes and heavy outer garments. Blood pressure (mmHg) was measured three 
times, on the right arm, in a sitting posture. The mean of the second and third measurements were used 
in analysis. Total cholesterol (mmol/l) was determined from serum samples, glucose (mmol/l) from 
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fasting (at least 8 hours) plasma samples and/or glycated haemoglobin (HbA1c) from EDTA blood 
samples.  
The availability of data on weight, height, and blood pressure was high in all surveys. For serum 
cholesterol, data was available only for 51% of the survey participants in survey E. In the other 
surveys, data was available for at least 90% of survey participants. Fasting blood samples were 
available for determination of plasma glucose in ten surveys (all except surveys C and E). For 
practical reasons, fasting blood samples were often collected only from those who came to the 
examination in the morning, i.e. had fasted overnight. Therefore, relatively low availability of data for 
fasting glucose (50% or less) was observed in surveys C, G and I. Glycated haemoglobin (HbA1c) was 
available in half the surveys (A, C E, F, H, I and K) and for almost all participants within these 
surveys. However, in survey E, only 51% of survey participants had HbA1c.  
Self-reported data  
Self-reported information is based on data collected from questionnaires as part of the EHES 
surveys 
18
. Survey participants were asked, before they were measured, “How tall are you without 
shoes? (in cm)” and “How much do you weight without clothes and shoes? (in kg)”. In countries, 
where Imperial units are commonly used, participants were allowed to provide information either in 
metric units or Imperial units. Imperial units were then transferred to metric units by the survey 
organizer. Self-reported height and weight were not asked in four surveys (I, J, K, L). 
The information on self-reported hypertension, high total cholesterol and diabetes was based on 
the question: “Do you have or have you ever had any of the following diseases or conditions, 
diagnosed by a medical doctor? (Yes/No) Myocardial infarction, Coronary heart disease or angina 
pectoris, High blood pressure (hypertension), Elevated blood cholesterol, Stroke (cerebral 
haemorrhage, cerebral thrombosis), Diabetes”. Diagnosed hypertension and diabetes were not asked in 
survey I, and diagnosed high blood cholesterol was not asked in two surveys (I and E).  
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The use of medication is based on self-reporting from the questions “During the past two weeks, 
have you used any medicines that were prescribed for you by a doctor?” and if yes, “Were the 
medicines for …? (Yes/No) High blood pressure, Lowering the blood cholesterol level, Diabetes”.  
Data on the use of medication for high blood pressure was not available in survey I; in three surveys 
(E, F and L), availability of data was less than 80%. For use of medications to lower blood cholesterol 
levels, data was not available in two surveys (I and E), and in two surveys (F and L) the data 
availability was less than 80%. Data on use of medications for diabetes was missing from survey I and 
in three surveys (E, F and L) the availability of data was less than 80%.   
Definition of indicators 
The definitions of the indicators for measured and self-reported overweight, obesity, hypertension, 
elevated blood cholesterol and diabetes are given in Table 1. 
In the calculation of the indicators, only persons for whom both the measured and self-reported 
data for that indicator were available were used. The age standardized means and prevalences were 
calculated separately for men and women aged 25-64 years. Each 10-year age group was weighted 
equally. 
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Table 1. Definition of indicators 
Data 
source 
Indicator Definition 
Objective 
measurements 
BMI Measured weight (kg) / measured height (m)
2
 
Overweight BMI, based on measured data ≥ 25 kg/m2 
Obesity BMI, based on measured data ≥ 30 kg/m2 
Hypertension Systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or being on drug treatment 
for hypertension (self-reported) 
Elevated total 
cholesterol 
Serum total cholesterol ≥ 5.0 mmol/l or being on drug treatment to lower blood cholesterol level (self-
reported) 
Diabetes Fasting plasma glucose ≥ 7.0 mmol/l or HbA1c (NGSP) ≥ 6.5% (IFFC HbA1c ≥ 48 mmol/mol) or being on 
drug treatment for diabetes (self-reported)  
Self-
reported 
BMI Self-reported weight (kg) / self-reported height (m)
2
 
Overweight BMI, based on self-reported data ≥ 25 kg/m2 
Obesity BMI, based on self-reported data ≥ 30 kg/m2 
Hypertension Has answered ‘Yes’ to question ‘Do you have or have you ever had any of the following diseases or 
conditions, diagnosed by a medical doctor?’ – ‘High blood pressure (hypertension)’ 
Elevated total 
cholesterol 
Has answered ‘Yes’ to question ‘Do you have or have you ever had any of the following diseases or 
conditions, diagnosed by a medical doctor?’ – ‘Elevated blood cholesterol’ 
Diabetes Has answered ‘Yes’ to question ‘Do you have or have you ever had any of the following diseases or 
conditions, diagnosed by a medical doctor?’ – ‘Diabetes’ 
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Analytical methods 
To test whether the observed differences between self-reported information and objective 
measurements between the populations were uniform, one-way variance analysis and log liner model 
were used.  
The sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV) 
were calculated for the indicators. Additionally, the percentage at risk that was missed by reliance 
solely on self-report, was calculated as: 
# of persons classified as not at risk by self-report but at risk by measurement data
# of persons classified as at risk by measurement data
 
to estimate the proportion of the population at risk for specific conditions (obesity, hypertension, high 
cholesterol and diabetes) which would be missed using only self-reported information. 
Results 
Anthropometry, overweight and obesity 
Mean measured height, over all populations, was 178.2 cm for men and 164.9 cm for women. 
These were 0.7 cm and 0.6 cm, respectively, less than mean self-reported height. The difference 
between measured and self-reported height varied significantly between populations but in general, 
self-reported height was higher than measured height. (Table 2) 
Mean measured weight, over all populations, was 85.4 kg for men and 70.0 kg for women. The 
self-reported weight was lower than the measured weight for men and women, by 1.3 kg and 1.4 kg 
respectively. The difference between measured and self-reported weight also varied significantly 
between populations but in all populations for women and in all except one for men, self-reported 
weight under-estimated measured weight. (Table 2)
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Table 2. Population mean of height, weight and BMI, and prevalence of overweight and obesity among 25-64 year old. Age standardized. 
Absolute difference between measured and self-reported indicators 
Survey Height cm Weight kg BMI kg/m
2
 Overweight % Obesity % 
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MEN 
A 582 182.3 182.2 0.1 580 87.5 85.9 1.6 527 26.4 25.9 0.5 61.7 55.4 6.3 15.1 11.7 3.4 
B 68 179.8 180.4 -0.6 67 88.5 87.0 1.5 67 27.4 26.7 0.7 71.1 68.4 2.7 23.6 18.1 5.5 
C 78 176.5 177.5 -1.0 77 85.6 85.4 0.2 77 27.5 27.1 04. 64.6 64.5 0.1 27.5 25.4 2.1 
D 50 177.6 177.9 -0.3 49 84.3 83.4 0.9 49 26.7 26.4 0.3 62.0 59.5 2.5 19.4 14.0 5.4 
E 344 176.0 177.3 -1.3 323 85.1 83.3 1.8 323 27.4 26.5 0.9 70.2 63.8 8.9 21.6 15.6 6.0 
F 188 174.6 176.0 -1.4 188 80.5 80.7 -0.2 188 26.4 26.0 0.4 54.1 54.6 -0.5 19.0 14.8 4.2 
G 53 174.2 175.3 -1.1 52 85.6 84.8 0.8 52 28.2 27.6 0.6 83.2 85.3 -2.1 28.9 19.8 9.1 
H 58 171.8 172.6 -0.8 71 83.4 81.3 2.1 56 27.9 27.0 0.9 72.7 69.6 3.1 24.5 17.1 7.4 
All surveys 1420 178.2 178.9 -0.7 1407 85.4 84.1 1.3 1384 26.9 26.2 0.7 64.9 60.5 4.4 18.6 14.2 4.4 
p-value for 
differences over 
all surveys 
0.0486 0.012 <0.0001 0.0083 0.001 
p-value for 
variation in 
differences 
between surveys 
< 0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
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WOMEN 
A 687 168.1 168.1 0.0 676 72.0 70.3 1.7 670 25.4 24.8 0.6 45.7 39.6 6.1 15.1 12.9 2.2 
B 95 164.4 164.8 -0.4 95 67.1 65.6 1.5 95 24.8 24.1 0.7 41.3 37.5 3.8 13.5 8.2 5.3 
C 110 165.3 166.3 -1.0 109 70.1 69.6 0.5 108 25.7 25.2 0.5 40.6 39.6 1.0 19.2 13.9 5.3 
D 81 164.3 164.2 0.1 80 64.8 64.4 0.4 80 24.0 23.9 0.1 35.1 33.7 1.4 5.1 5.1 0.0 
E 440 162.9 163.7 -0.8 399 72.7 70.5 2.2 398 27.4 26.3 1.1 62.5 52.1 10.4 28.0 20.3 7.7 
F 205 162.4 164.4 -2.0 205 63.7 63.4 0.3 205 24.2 23.4 0.8 36.5 29.2 7.3 11.6 7.2 4.4 
G 56 158.8 161.5 -2.7 57 70.7 70.2 0.5 55 28.6 27.2 1.4 56.3 57.1 -0.8 35.3 26.5 8.8 
H 61 158.1 159.4 -1.3 77 67.7 66.4 1.3 61 27.0 25.9 1.1 54.7 50.0 4.7 30.5 24.7 5.8 
All surveys 1735 164.9 165.5 -0.6 1698 70.0 68.6 1.4 1672 25.8 25.0 0.8 47.7 41.6 6.1 18.1 13.9 4.2 
p-value for 
differences over 
all surveys 
0.004 0.0024 <0.0001 0.0002 0.0004 
p-value for 
variation in 
differences 
between surveys 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
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The measured BMI over all populations was 0.7 kg/m
2
 higher than the self-reported BMI among 
men. For women, the difference was 0.8 kg/m
2
. Variation in the difference between measured and self-
reported BMI between populations was significant and larger among women than men. (Table 2) 
Over all populations, the prevalence of overweight, based on measurements, was 64.9 % for men 
and 47.7 % for women. These were 4.4 percentage points and 6.1 percentage points higher than the 
prevalence of overweight based on self-reported information. The variation in the difference between 
measured and self-reported prevalence of overweight was significant between populations. (Table 2) 
The prevalence of obesity, over all populations, from measurements was 18.6 % for men and 18.1 
% for women. The prevalence of obesity from self-reported information was lower for men and 
women, by 4.4 percentage point and 4.2 percentage points respectively. Similar to the prevalence of 
overweight, the differences between countries in under-estimation of prevalence of obesity by self-
reported data varied considerably between populations; this variation was statistically significant. 
(Table 2) 
Hypertension 
The prevalence of hypertension, over all populations, from measurements was 32.7 % among men 
and 21.9% among women. For men, the self-reported prevalence of hypertension was 10.1 percentage 
points lower than prevalence based on measurements, while for women the self-reported prevalence 
was 3.5 percentage points higher than that based on measurement of blood pressure. There was 
significant variation in this between populations for both men and women. (Table 3) 
Elevated total cholesterol 
In both men and women, the prevalence of elevated total cholesterol based on measurements was 
higher than the self-reported prevalence of elevated total cholesterol. The measured prevalence of 
elevated total cholesterol, all populations combined, was 71.1% for men and 62.6% for women. 
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Table 3. Prevalence of hypertension, high cholesterol and diabetes among 25-64 year old. Age standardization. Absolute difference between 
measured and self-reported indicators.  
Survey Prevalence of hypertension (%) Prevalence of high cholesterol 
(%) 
Prevalence of diabetes (%) 
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MEN 
A 575 36.0 18.9 17.1 540 73.2 17.5 55.7 468 6.5 6.1 0.4 
B 69 31.5 16.4 15.1 69 69.4 22.0 47.4 67 4.0 4.3 -0.3 
C 48 25.8 24.6 1.2 48 72.5 28.3 44.2 n.a n.a n.a n.a 
D 70 29.7 31.1 -1.4 66 67.6 27.1 40.5 70 12.4 11.2 1.2 
E 187 32.2 33.0 -0.8 n.a n.a n.a n.a 123 8.1 8.1 0.0 
F 186 31.3 25.0 6.3 84 58.8 31.6 27.2 87 5.7 5.6 0.1 
G 53 19.4 13.2 6.2 49 70.6 23.8 46.8 16 0.0 4.2 -4.2 
H 80 38.3 19.0 19.3 81 75.6 15.4 60.2 82 9.8 9.4 0.4 
J 81 32.3 24.2 8.1 80 70.7 29.4 41.3 80 5.1 4.1 1.0 
K 39 40.3 30.4 9.9 32 73.1 35.4 37.7 31 0.0 0.0 0.0 
L 52 13.0 11.2 1.8 52 56.4 5.9 50.5 51 8.1 4.7 3.4 
All surveys 1440 32.7 22.6 10.1 1101 71.1 21.5 49.6 1075 6.6 5.8 0.8 
p-value for differences over all 
surveys 
<0.0001 <0.0001 0.2101 
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p-value for variation in differences 
between surveys 
<0.0001 <0.0001 <0.0001 
WOMEN 
A 630 25.1 28.5 -3.4 556 62.6 14.9 47.7 486 4.6 4.9 -0.3 
B 96 25.2 12.5 12.7 94 69.2 22.6 46.6 93 0.8 0.8 0.0 
C 80 12.8 13.7 -0.9 80 72.5 22.0 50.5 n.a n.a n.a n.a 
D 101 19.1 18.8 0.3 96 60.0 19.5 40.5 102 3.3 5.4 -2.1 
E 218 27.0 42.1 -15.1 n.a n.a n.a n.a 128 9.5 9.5 0.0 
F 202 14.0 19.3 -5.3 104 62.9 28.6 34.3 107 2.1 4.8 -2.7 
G 58 12.2 11.8 0.4 50 64.4 21.4 43.0 15 0.0 6.3 -6.3 
H 80 27.4 16.3 11.1 74 18.4 19.7 -1.3 74 5.9 7.0 -1.1 
J 86 30.7 26.6 4.1 86 59.1 16.6 42.5 84 5.3 4.8 0.5 
K 57 36.5 42.4 -5.9 48 58.6 42.6 16.0 46 3.2 6.0 -2.8 
L 53 10.8 16.0 -5.2 52 45.0 8.5 36.5 53 0.0 0.0 0.0 
All surveys 1661 21.9 25.4 -3.5 1240 62.6 19.0 43.6 1188 3.9 4.8 -0.9 
p-value for differences over all 
surveys 
0.0089 <0.0001 0.1339 
p-value for variation in differences 
between surveys 
<0.0001 <0.0001 <0.0001 
n.a.: data not available 
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Among men, the measured prevalence of elevated total cholesterol was 49.6 percentage points and 
among women 43.6 percentage points higher than self-reported prevalence. There was significant 
variation between populations. (Table 3) 
Diabetes 
The prevalence of diabetes based on measurements was 6.6% among men and 3.9% among 
women, all populations combined. Among men, the measured prevalence of diabetes was 0.8 
percentage points higher than self-reported, while in women, the measured prevalence was 0.9 
percentage points lower than self-reported. The pattern was mixed between populations but variation 
was statistically significant (Table 3). 
Proportion at risk missed by self-reported information 
Assuming that results from the objective measurements during the survey represent the true 
situation in the population, we estimated the proportion of the population at risk which would be 
missed by estimates based on self-reported data. For obesity, 30% of obese men and 26% of obese 
women would be missed by self-reported data. Similarly 41% of hypertensive men and 28% of 
hypertensive women; 68% of men and 70% of women with elevated total cholesterol; and 22% of 
diabetic men and 14% of diabetic women would be missed by self-reported data (Table 4).
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Table 4. Proportion at risk that was missed by reliance solely on self-report, and sensitivity and specificity of the self-reported information 
 Data based on objective measurements 
Obesity Hypertension High cholesterol Diabetes 
Men Women Men Women Men Women Men Women 
Yes No Yes No Yes No Yes No Yes No Yes No Yes No Yes No 
S
el
f-
re
p
o
rt
ed
 d
a
ta
 Yes 185 18 232 7 304 60 304 154 250 15 237 27 62 9 43 17 
No 81 1100 81 1352 214 830 120 1068 534 259 557 367 17 986 7 1121 
% at risk 
missed 
30% 26% 41% 28% 68% 70% 22% 14% 
Sensitivity 70% 74% 59% 72% 32% 30% 78% 86% 
Specificity 98% 99% 93% 87% 95% 93% 99% 99% 
PPV 91% 97% 84% 66% 94% 90% 87% 72% 
NPV 93% 94% 80% 90% 33% 40% 98% 99% 
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Discussion 
Observed bias of self-reported information 
Our results show that there is clear under-estimation of the population prevalence of overweight, 
obesity and elevated total cholesterol for both men and women when compared with objective 
measurements. For the prevalence of hypertension and diabetes, under-estimation of self-reported 
information was observed in men but not as clearly in women. These results are in line with the results 
from previous studies 
8,14
. 
Previous studies have shown that self-reported height is up to 2.2 cm greater than measured height 
in the general population among both men and women. For weight, self-reported values have been 
consistently lower than measured values, by up to 1.6 kg in men and women. The reporting bias has 
been larger among overweight and obese people. 
14
 These results are similar to our findings, 
supporting the general impression that people tend to report that they are taller and leaner than they 
really are. For over-reporting of height, it also may be that people have had their height measured over 
a decade(s) ago, and with increasing age, people tend to become shorter 
19
.   
The observed over-reporting of height and under-reporting of weight has a direct impact on BMI 
levels and thus to the prevalence of overweight and obesity. Our results showed under-estimation of 
BMI similar to results from USA and Ireland 
13,20
. Results from the National Health and Nutrition 
Examination Survey (NHANES) in the USA show that error in self-reported BMI increases with age 
20
 
and there are differences between ethnic groups in the reporting bias 
21
. Irish results have 
demonstrated that miss-reporting of height and weight, and thus under-estimation of BMI has 
increased over time;  particularly among overweight and obese individuals 
13
. 
In previous studies, prevalence of self-reported hypertension has been one to 39 percentage points 
lower than prevalence based on measured data. Our results showed slightly smaller difference. This 
reduced difference may be explained by increased awareness of hypertension over time, which has 
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been reported from several countries 
22-25
.  Regardless of this positive development, the difference 
between self-reported and measured hypertension prevalence remains large. 
For elevated total cholesterol, the self-reported prevalence has been around 30 percentage points 
lower than prevalence based on measurement in previous studies 
7,10,12
. In our study, differences 
between prevalence of self-reported and measured elevated total cholesterol were significantly larger. 
This difference may be explained by different definitions of measured elevated total cholesterol. In 
some of the previous studies, the definition has been based on observed total cholesterol level (≥ 5.0 
mmol/l) only. In our definition of measured elevated total cholesterol, people who reported that they 
were using medicines to lower their blood cholesterol levels were also considered as having elevated 
total cholesterol. It could also be that people under medical treatment for high cholesterol who have 
their cholesterol levels under control (< 5.0 mmol/l), do not report having high cholesterol for self-
reported question.  
For diabetes, our results showed rather small differences which were not systematic between 
populations or sexes. In previous studies, the difference between self-reported and measured 
prevalence of diabetes has been 1-2 percentage points 
7,10
. In our study, we had a very small numbers 
of cases, which may have affected the outcome. There is also some evidence that HbA1c would 
diagnose less diabetes than an oral glucose tolerance test but would work as well as a fasting glucose 
test
26
.  
For self-reported information, people have to know their condition before they can report it. 
Awareness of a specific health condition requires an examination and diagnosis by a medical doctor. 
Since most health conditions included in this study are asymptomatic for a long time, people do not 
have a reason to seek medical treatment for them. This is often a reason for under-reporting of self-
reported health conditions.  
  
 18 
 
Strengths and limitation of our study 
In the EHES Pilot Project, the data on self-reported medical conditions can be compared with 
objective measurements taken during the health examination surveys. The strengths of our study are 
the use of standardized survey methods (sampling, questions, and measurement protocols) across the 
countries and external quality control. 
18
 The standardized protocols ensure that observed deviations in 
the results between populations are not due to differences in measurement techniques. This was 
supported with external quality control actions. We have both self-reported and measured data from 
the same individuals, who were working age men and women from several countries. 
The sample sizes for these pilot surveys were relatively small and represented only small areas 
within the various countries. Therefore, survey specific results cannot be generalized to any specific 
country but analysis show variation in extend of under-recording between different survey 
populations. 
In health examination surveys with physical examinations and collection of blood samples, a 
definition of health conditions is based on measurements taken on a single occasion during the survey. 
A medical diagnosis of hypertension, hypercholesterolaemia or diabetes is generally based on several 
subsequent measurements. Therefore health examination surveys can over- or under-estimate the true 
prevalence of specific health conditions in the population.  
Implications for health policy planning 
In 2008, 63% of deaths in the world were due to non-communicable diseases (NCD), primarily 
cardiovascular diseases, diabetes, cancer and chronic respiratory disease. Most of the NCDs are 
strongly associated with raised blood pressure, overweight and obesity, hyperglycaemia and 
hyperlipidaemia. The leading NCD risk factor globally is raised blood pressure, contributing to 13% of 
NCD deaths. Tobacco use, hyperglycaemia, physical inactivity, overweight and obesity, and high 
cholesterol are also very important. 
27
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A large proportion of NCDs could be prevented through changes in these risk factors:  even a 2 
mmHg lower systolic blood pressure would result in about a 10% reduction in stroke mortality and 
about 7% lower mortality from ischemic heart disease or other vascular causes in the middle age. 
28
 
Similarly, 1 mmol/l lower total cholesterol leads to about one-third lower ischemic heart disease 
mortality 
29
 and one unit lower BMI means a 4% and 3% lower fatal and non-fatal cardiovascular risk 
in men and women respectively 
30
. 
Geoffrey Rose proposed that small, population wide-changes in risk factor profiles would be more 
effective than large changes in smaller, high risk sub-groups of the population 
31
. Thus information 
required for identifying the extent of a problem in the population, developing and implementing a 
policy, targeting it to appropriate sub-groups of the population, and monitoring and evaluation of the 
progress needs to cover the whole population, not only patients in the health care system. Such 
information is not available from administrative registers. Although health examination surveys are 
more expensive than interview surveys, they provide more accurate information on the health and 
health risks of the population. Policy makers use the additional information extensively and are very 
appreciative of its usefulness 
32
. 
Conclusions 
Our results have confirmed that self-reported information tends to under-estimate population 
prevalence of overweight, obesity, hypertension, high total cholesterol and diabetes. Using 
standardized protocols, we have demonstrated that under-estimation is not uniform between 
populations or population sub-groups. Objective measurements taken during health examination 
surveys provide more accurate information about the health of the population for supporting evidence 
based health policies. 
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Key points 
 Self-reported information on health indicators under-estimated population means and 
prevalences. 
 Under-estimation of population level health indicators by self-reported information is 
not uniform between populations. 
 A large proportion of people at risk are missed if only self-reported information is used. 
 Reliance on self-reported information alone for health policy is likely to lead to under-
estimation of the health problems in the population. 
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Annex I. Sites and key personnel contributing to the EHES 
Pilot Project 
 
Czech Republic 
National Institute of Public Health, Prague: Ruzena Kubinova, Nada Capkova, Jana Kratenova  
and Michala Lustigova 
Finland 
National Institute for Health and Welfare (THL). EHES Reference Centre: Kari Kuulasmaa, Hanna 
Tolonen, Katri Kilpeläinen, Päivikki Koponen, Sanna Ahonen, Johanna Mäki-Opas, Ari Haukijärvi, 
Tarja Tuovinen, Georg Alfthan, Jari Kirsilä; 
National pilot survey: Satu Männistö, Katja Borodulin, Liisa Saarikoski, Anne Juolevi, Markku 
Peltonen, Tiina Laatikainen, Erkki Vartiainen, Jouko Sundvall, Laura Lund, Antti Jula, Eija Purkamo. 
Germany 
Robert Koch Institute, Berlin. For the DEGS Study Team: Antje Gösswald, Cornelia Lange, 
Panagiotis Kamtsiuris. 
Greece 
Hellenic Health Foundation, Athens. Antonia Trichopoulou, Valentini Konstantinidou, Androniki 
Naska, Dimosthenis Zilis, Vardis Dilis, George Adarakis, Ioulia Goufa, Georgia Stasinopoulou, 
Elisabeth Valanou, Perikles Karathanasis, Nikolaos Bilalis, Philippos Orfanos, Tina Karapetyan, 
Despina Oikonomidou, Eirini Frangogeorgi and Konstantinos Mine. 
Italy 
Istituto Superiore di Sanità, Rome. EHES Reference Centre: Susanna Conti, Mark Kanieff; 
National Pilot Survey: Luigi Palmieri, Chiara Donfrancesco, Cinzia Lo Noce, Francesco Dima, 
Giuseppe Salamina, Maria Piera Vettori, Amalia De Curtis, Licia Iacoviello, Diego Vanuzzo, Simona 
Giampaoli. 
Malta 
Department of Health Information & Research, Gwardamangia: Neville Calleja, Dorothy Gauci. 
The Netherlands 
National Institute of Public Health and the Environment (RIVM), Bilthoven: W.M.Monique 
Verschuren. 
Norway 
Norwegian Institute of Public Health: Grethe S. Tell, Patricia Schreuder, Sidsel Graff-Iversen, Nina 
Hovland; University of Bergen: Kristin Klock; 
Statistics Norway. EHES Reference Centre: Johan Heldal, Susie Jentoft. 
Poland 
The Cardinal Stefan Wyszynski Institute of Cardiology, Warsaw: Grażyna Broda, Aleksandra 
Piwonska, Jerzy Piwoński, Paweł Kurjata, Walerian Piotrowski, Maria Polakowska, Anna 
Waśkiewicz, Elzbieta Sygnowska. 
Portugal 
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Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon: Carlos Matias Dias, Ana Paula Gil, Marta 
Barreto, Eleonora Paixão, AUsenda Machado, Filomena Martins. 
Regional Health Administration, Algarve: Francisco Mendonça, Filomena Orta Correia, Ana Cristina 
Guerreiro, Estela Fabião. 
Regional Public Health Laboratory; Álvaro Beleza, Aida Fernandes, Paula Rasteiro, Eduardo Sousa. 
Slovakia 
Regional Authority of Public Health, Banská Bystrica. Maria Avdicova, Katarina Francisciova, Jana 
Namesna, Silvia Kontrosova. 
UK 
UCL (University College London), London: Jennifer Mindell, Nicola Shelton, Barbara Carter-
Szatynska, Alison Moody; 
Health and Social Care Information Centre, London: Rachel Craig, Susan Nunn, Deanna Pickup, 
Chloe Robinson; 
The NHS Information Centre: Steve Webster, Victoria Cooper. 
 
